High Court Spurns Pharma Challenges To IRA Drug Price Talks
By Dan McKay · May 18, 2026, 10:15 AM EDT
The U.S. Supreme Court on Monday rejected six petitions from pharmaceutical giants seeking to bring down the Medicare drug price negotiations established as part of the Inflation Reduction Act three years...
To view the full article, register now.